×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Loan Against Mutual Fund
Apply Now
Gold Loan
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Eco Pulse
MC Learn
Elections 2026
Seasonality Analysis
Big Shark Portfolios
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Global Wealth Summit
Unlocking opportunities in Metal and Mining
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
IPL 2026
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
PF
Forum
Videos
you are here:
Home
News
Zydus
Zydus
Delhi High Court allows Zydus to sell cheaper biosimilar of cancer drug Nivolumab in public interest
Zydus enters biologics CDMO with acquisitions valued at $125 million
Nifty Pharma settles 2% higher on exclusion from Trump's reciprocal tariffs; Lupin, IPCA Labs up 5%
Indian pharma players can deliver 100 new drugs by 2047: Zydus Chairman
Trump Tariff – How much can it hurt Indian pharma?
Stocks on Radar | Mankind Pharma, Zydus Lifesciences, Ashoka Buildcon, Hero Motocorp in Focus
Zydus Lifesciences to buy Perfect Day's 50% stake in Sterling Biotech to forge a 50:50 JV
Zydus gets Mexican regulatory approval to market cancer treatment product
Zydus Lifesciences gets USFDA nod for generic drug to prevent chest pain in heart patients
Zydus launches pill for prostate cancer patients
Zydus gets USFDA nod for generic medication for postherpetic neuralgia
Zydus Life subsidiary gets Income Tax demand of Rs 280 cr
Zydus gets USFDA nod for antiviral drug used in HIV treatment
Zydus receives final approval from USFDA for Methylene Blue Injection
Zydus Lifesciences: Why we are getting constructive
Lupin, Zydus Lifesciences ink licensing and supply pact for Saroglitazar Mg
Zydus Life to acquire LiqMeds Group for Rs 689 crore
Zydus, Sun Pharma to co-market oral drug for anaemia linked to kidney diseases
Moneycontrol Selects: Top stories this evening
Zydus Lifesciences: Time to book profit, post strong rally over a year?
Delhi HC bars Zydus Wellness from using ‘SugarLite’ brand name
Zydus recalls over 55,000 bottles of generic drug in US
Zydus Lifesciences gets USFDA nod to market generic drug to lower cholesterol levels
Zydus, Medtronic partner for first AI-based stroke care network in Gujarat
Zydus, Baba Ramdev firm among 16 barred from selling drugs in Nepal
View More
Home
Markets
Loans
Gold Loan
News
Portfolio